Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$168K Buy
1,159
+562
+94% +$77.7K 0.05% 121
2026
Q2
$76.7K Hold
597
– – 0.04% 49
2026
Q1
$71.8K Hold
597
– – 0.04% 46
2025
Q4
$62.8K Hold
597
– – 0.03% 41
2025
Q3
$50.1K Hold
597
– – 0.03% 46
2025
Q2
$47.3K Sell
597
-279
-32% -$22.2K 0.04% 41
2025
Q1
$78.6K Buy
876
+79
+10% +$7.38K 0.06% 36
2024
Q4
$79.3K Buy
797
+200
+34% +$20.6K 0.06% 28
2024
Q3
$67.8K Hold
597
– – 0.05% 25
2024
Q2
$73.9K Hold
597
– – 0.06% 22
2024
Q1
$78.8K Hold
597
– – 0.07% 20
2023
Q4
$65.1K Hold
597
– – 0.08% 21
2023
Q3
$61.5K Hold
597
– – 0.11% 21
2023
Q2
$68.9K Hold
597
– – 0.17% 17
2023
Q1
$63.5K Hold
597
– – 0.26% 18
2022
Q4
$66.2K Hold
597
– – 0.11% 19
2022
Q3
$51K Hold
597
– – 0.09% 22
2022
Q2
$54K Hold
597
– – 0.14% 23
2022
Q1
$48K Hold
597
– – 0.04% 24
2021
Q4
$45K Buy
+597
New +$47.6K 0.03% 36
2021
Q1
– Sell
-626
Closed -$48K – 102
2020
Q4
$48K Buy
+626
New +$47.9K 0.04% 46

Other funds holding MRK

IFS Advisors's MRK Position: Q3 2026 in Review

IFS Advisors increased its Merck (MRK) stake by 94% in Q3 2026, buying an estimated $77.7K and bringing the position to 1,159 shares worth $168K. The position accounts for 0.05% of the portfolio, ranked #121.

IFS Advisors first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • IFS Advisors held 1,159 shares of Merck worth $168K as of Q3 2026.
  • IFS Advisors bought 562 Merck shares in Q3 2026, an estimated $77.7K.
  • Merck made up 0.05% of IFS Advisors's portfolio in Q3 2026, its #121 holding.
  • IFS Advisors first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.